WCG

WCG is a groundbreaking startup in the health care and pharmaceutical industries, dedicated to accelerating research and improving lives. Established in 2012 and headquartered in the United States, the company's slogan "We improve lives by accelerating research, together." encapsulates its mission. With a 55-year legacy, WCG is a trusted partner for research sponsors, CROs, sites, and participants, offering independent ethical review solutions that set industry standards. Its commitment to reimagining processes, leveraging data and technology, and optimizing quality and safety is driving innovation in the clinical research journey. In November 14, 2019, WCG secured a Private Equity Round investment from distinguished investors, including Novo Holdings, Arsenal Capital Partners, and Leonard Green & Partners. This investment underscores confidence in WCG's highly specialized solutions and data-driven insights, as well as its pivotal role in mitigating risk for 90% of all clinical trials. WCG's approach not only liberates study stakeholders from constraints that risk trial efficacy, but also enhances efficiency and quality outcomes, promising a more impactful tomorrow.